1. Mazin, Mark E, Yarushkin, Andrei A, Pustylnyak, Yuliya A, Prokopyeva, Elena A, Pustylnyak, Vladimir O. 2022. Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation. In Molecular biology reports, 49, 4089-4093. doi:10.1007/s11033-022-07340-1. https://pubmed.ncbi.nlm.nih.gov/35305226/
2. Mbatchi, Litaty Céphanoée, Brouillet, Jean-Paul, Evrard, Alexandre. 2017. Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability. In Pharmacogenomics, 19, 61-77. doi:10.2217/pgs-2017-0121. https://pubmed.ncbi.nlm.nih.gov/29199543/
3. de Almeida Velozo, Camila, de Almeida, Tailah Bernardo, de Azevedo, Marcelo Costa Velho Mendes, Ribeiro-Alves, Marcelo, Cardoso, Cynthia Chester. 2021. Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals. In The pharmacogenomics journal, 22, 33-38. doi:10.1038/s41397-021-00254-4. https://pubmed.ncbi.nlm.nih.gov/34504302/
4. Liu, Jiabao, Malekoltojari, Ainaz, Asokakumar, Anjana, Peng, Hui, Krause, Henry M. 2024. Diindoles produced from commensal microbiota metabolites function as endogenous CAR/Nr1i3 ligands. In Nature communications, 15, 2563. doi:10.1038/s41467-024-46559-3. https://pubmed.ncbi.nlm.nih.gov/38519460/
5. Chew, Sin Chi, Lim, Joanne Siok Liu, Singh, Onkar, Lee, Edmund J D, Chowbay, Balram. 2012. Genetic variations of NR1I3 and NR2B1 in Asian populations. In Drug metabolism and pharmacokinetics, 28, 169-76. doi:. https://pubmed.ncbi.nlm.nih.gov/22850739/
智鼠故事 
